Skip to content

Clinical trials

Muscular Dystrophies trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20121
20131
20141
20171
20213
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Active, not recruiting3
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
PTC Therapeutics2
Sarepta Therapeutics, Inc.2
Vertex Pharmaceuticals Incorporated2
Avidity Biosciences, Inc.1
BioMarin Pharmaceutical1
Hoffmann-La Roche1
Kyntra Bio1
Satellos Bioscience, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies14
Muscular Dystrophy, Duchenne11
Muscular Diseases7
Neuromuscular Diseases7
Genetic Diseases, Inborn6
Muscular Disorders, Atrophic6
Musculoskeletal Diseases6
Nervous System Diseases6
Genetic Diseases, X-Linked3
Myotonic Dystrophy3

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.